ZIOP - ZIOPHARM Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5677.11M
Enterprise Value 3721.01M
Trailing P/E 4.51
Forward P/E 1-13.59
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)
Price/Book (mrq)11.30
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-13.58

Trading Information

Stock Price History

Beta (3Y Monthly) 3.17
52-Week Change 337.92%
S&P500 52-Week Change 32.99%
52 Week High 37.2500
52 Week Low 31.5600
50-Day Moving Average 35.0866
200-Day Moving Average 34.7904

Share Statistics

Avg Vol (3 month) 31.89M
Avg Vol (10 day) 31.62M
Shares Outstanding 5162.55M
Float 137.74M
% Held by Insiders 12.12%
% Held by Institutions 144.18%
Shares Short (Aug 15, 2019) 446.02M
Short Ratio (Aug 15, 2019) 424.81
Short % of Float (Aug 15, 2019) 428.94%
Short % of Shares Outstanding (Aug 15, 2019) 428.31%
Shares Short (prior month Jul 15, 2019) 447.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 240/1
Last Split Date 3Aug 24, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.89%
Return on Equity (ttm)-137.64%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-33.99M
EBITDA -53.09M
Net Income Avi to Common (ttm)147.82M
Diluted EPS (ttm)0.9640
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)43.56M
Total Cash Per Share (mrq)0.27
Total Debt (mrq)1.44M
Total Debt/Equity (mrq)2.32
Current Ratio (mrq)6.33
Book Value Per Share (mrq)0.38

Cash Flow Statement

Operating Cash Flow (ttm)-38.65M
Levered Free Cash Flow (ttm)-35.97M